-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How Do I Sequence Therapy for Follicular Lymphoma?

Program: Education Program
Session: Indolent Lymphomas: Answers to Smoldering Questions
Hematology Disease Topics & Pathways:
Follicular Lymphoma, Biological, therapy sequence, Diseases, Therapies, Combinations, Non-Hodgkin Lymphoma, Lymphoid Malignancies
Sunday, December 6, 2020, 11:55 AM-12:00 PM

Gilles Salles, MD, PhD

Centre Hospitalier Lyon-Sud, Lyon, France

Disclosures: Salles: Takeda: Consultancy, Honoraria, Other; Bristol Myers Squibb: Consultancy, Other; F. Hoffman-La Roche Ltd: Consultancy, Honoraria, Other; Autolus: Consultancy; Abbvie: Consultancy, Honoraria, Other: Participation in educational events; Amgen: Honoraria, Other: Participation in educational events; Karyopharm: Consultancy; Kite: Consultancy, Honoraria, Other; Janssen: Consultancy, Honoraria, Other: Participation in educational events; Genmab: Consultancy; Epizyme: Consultancy; Celgene: Consultancy, Honoraria, Other: Participation in educational events; Debiopharm: Consultancy; MorphoSys: Consultancy, Honoraria, Other; Novartis: Consultancy, Honoraria, Other; Gilead: Consultancy, Honoraria, Other: Participation in educational events.

OffLabel Disclosure: lenalidomide CAR-T cells

See more of: Indolent Lymphomas: Answers to Smoldering Questions
See more of: Education Program
Previous Presentation | Next Presentation >>